Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling
Sign Up to like & getrecommendations! Published in 2022 at "Vaccine"
DOI: 10.1101/2022.05.23.22275466
Abstract: In recent decades, there has been an increased interest in developing a vaccine for chikungunya. However, due to its unpredictable transmission, planning for a chikungunya vaccine trial is challenging. To inform decision making on the… read more here.
Keywords: trial; chikungunya vaccine; vaccine trial; endpoint events ... See more keywords
Recent development in the strategies projected for chikungunya vaccine in humans
Sign Up to like & getrecommendations! Published in 2018 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s181574
Abstract: The unprecedented epidemic spread of chikungunya worldwide illustrates the critical need for potent vaccines and therapeutic interventions. The morbidity and mortality associated with this arboviral infection has become a major public health problem in many… read more here.
Keywords: chikungunya vaccine; strategies projected; development strategies; recent development ... See more keywords
Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s366112
Abstract: Abstract Chikungunya virus (CHIKV) is an alphavirus that has spread globally in the last twenty years. Although mortality is rather low, infection can result in debilitating arthralgia that can persist for years. Unfortunately, no treatments… read more here.
Keywords: current landscape; vaccine candidates; future prospects; chikungunya vaccine ... See more keywords